Neuspera Medical
PrivateLast Round
Series D
Jul 15, 2024
Total Funding Raised
$149M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuspera Medical operates in Healthcare & Life Sciences and is based in San Jose, California. Its latest recorded funding round was a Series D round in July 2024.
Neuspera Medical is a medical technology company that develops implantable neuromodulation devices aimed at enhancing the quality of life for patients with chronic illnesses through less invasive and more adaptable treatment options.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuspera Medical Comparables
Compare Neuspera Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BlueWind Medical | 90% | |
| SacraMed | 87% | |
| Medtronic | 82% |
For institutional investors. Book with your work email.
Neuspera Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 15, 2024 | ||||
| Series C | Jul 20, 2021 | ||||
| Series B | Feb 20, 2019 | ||||
| Series B | Jan 24, 2018 | ||||
| Series A | May 12, 2016 | ||||
Angel | May 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neuspera Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Olympus Innovation Ventures | Series D |
| Vertex Ventures HC | Series C, Series D |
| Orion Capital Asia | Series D |
| Action Potential Venture Capital | Series B, Series A, Series C, Series D |
| Alumni Ventures | Series B |
| Windham Capital Partners | Series C, Series B, Series A, Series D |
| 6 Dimensions Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 95% MoM, from 1.7K to 3.3K.
- Jun 22, 2026
Monthly visitors increased 124% MoM.
For institutional investors. Book with your work email.
Neuspera Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neuspera Medical's valuation, stock price, and market status.
Is Neuspera Medical a public or private company?
Neuspera Medical is a private company.
What is the current stock price of Neuspera Medical?
Neuspera Medical is a private company, so its shares have no public market price. Caplight tracks Neuspera Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuspera Medical worth (valuation)?
Valuation information for Neuspera Medical is not publicly available.
Can I buy Neuspera Medical stock?
Neuspera Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuspera Medical's last funding round?
Neuspera Medical's most recent funding round was Series D on July 15, 2024.
Who are the main investors in Neuspera Medical?
Key investors in Neuspera Medical include Vertex Ventures HC, 6 Dimensions Capital, Treo Ventures.
Will Neuspera Medical IPO soon?
No public IPO plans have been announced for Neuspera Medical.
How can I track Neuspera Medical secondary market activity?
Caplight tracks bids, offers, and trades in Neuspera Medical's shares on secondary markets.